Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia.
Acute febrile neutrophilic dermatosis (Sweet syndrome) has been reported in a few adults receiving all-trans retinoic acid for acute promyelocytic leukemia. The authors report a case of Sweet syndrome associated with the administration of all-trans retinoic acid for acute promyelocytic leukemia in a pediatric patient.
Al-Saad
Khulood
K
Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada.
Khanani
Muhammad Faisal
MF
Naqvi
Ahmed
A
Krafchik
Bernice
B
Grant
Ron
R
Pappo
Alberto
A
D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012867:Skin / Q000473:pathology; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000473:pathology; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects*
D000970:Antineoplastic Agents; D014212:Tretinoin